Comparative Toxicokinetics and Cross-Species Extrapolation in IND Studies
Comparative toxicokinetics (TK) play a fundamental role in evaluating systemic exposure across species used in regulatory toxicology. These data are essential for bridging animal study results to human risk assessment, particularly in the context of Investigational New Drug (IND) applications. TK profiles are assessed in both rodent and non-rodent species during single- and repeated-dose toxicity studies, measuring parameters such as Cmax, AUC, half-life, and clearance.
Species-specific differences in absorption, distribution, metabolism, and excretion (ADME) must be carefully analyzed to interpret toxicological findings and guide human dose projections. For instance, a compound that shows no adverse effects in rats may accumulate at higher concentrations in primates due to slower clearance, necessitating reevaluation of safety margins. When animal exposure levels are significantly below those anticipated in humans, regulators may require reformulation, additional studies, or mechanistic explanations.
Integration of TK data with pharmacokinetic/pharmacodynamic (PK/PD) models enables better dose selection, supports NOAEL interpretation, and ensures translational relevance of animal models. Toxicokinetic comparisons across species also inform the choice of sentinel species for chronic studies and help justify study design in the IND package.